aDivision of HIV, Infectious Diseases, and Global Medicine

bDivision of Experimental Medicine

cDepartment of Epidemiology and Biostatistics, University of California, San Francisco

dMonogram Biosciences, South San Francisco

eCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI)

fDepartment of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla

gDivision of Laboratory Medicine

hDivision of Cardiology, University of California, San Francisco, CA, USA.

Correspondence to Michael J. Peluso, MD, Assistant Professor of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, 1001 Potrero Avenue, San Francisco, CA 94110, USA. Tel: +1 415 476 4082 x119; e-mail: [email protected]

Received 23 May, 2022

Revised 14 June, 2022

Accepted 29 June, 2022

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com).